| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
Nasdaq: ACDO |
| Security Type |
Common Stock |
| Lead Underwriter |
Hambrecht & Quist |
| Days In Registration |
226 |
| Date Filed |
1-Sep-1998 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Healthcare |
| Business Description |
Provide specialized contract pharmacy, clinical, reimbursement, delivery and other related services beneficial to patients with certain costly, chronic diseases such as gaucher disease, hemophilia, multiple sclerosis and growth hormone-related disorders |
| Revenue |
$256.4M |
| Net Income |
$4.4M |
| Shares Outstanding (post-offering) |
8.63M |
| Chief Executive Officer |
David D. Stevens |
| Number of Employees |
480 |
|
| Original Filing Information |
| US |
| Shares Filed |
3.0M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
3.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
450.0K |
| File Amount |
$48.0M |
| File Price Range |
$17.00 - $15.00 |
| File Mid Price |
$16.00 |
Current Filing Information
(Amended 15-Apr-1999) |
|
US |
|
Shares Filed |
3.0M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
3.0M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$48.0M |
| · % Change from Original |
0.0 |
| File Price Range |
$17.00 - $15.00 |
| File Mid Price |
$16.00 |
|
